GGrantIndex
← Leaderboards

Mack T Ruffin

University Of Pittsburgh At Pittsburgh

$5,808,265
Attributed
$8,496,016
Total exposure
8
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,496,016 · 8

By mechanism

R01$5,375,502 · 2
P50$1,710,794 · 2
K24$1,344,046 · 1
M01$65,674 · 3

Top collaborators

Most similar at University Of Pittsburgh At Pittsburgh

Same institution · by research overlap

Others in their field

Top investigators on “Interest

Research focus

InterestParticipantBaseAdultProgramsLinkLesionColorectal CancerHuman PapillomavirusTrainingPatternSerumMalignant NeoplasmsCharacteristicsResponseAntibodiesProteinsReportingRisk FactorsMethodologyBiomarkerCarotenoidsCancer PreventionArea

Grant awards (34)

Increasing Physical Activity in Rural Pennsylvanians: The PA Moves Trial$977,596
R01 · FY2025 · CA
PSE obesity supplement to PA Moves$100,000
R01 · FY2025 · CA
Increasing Physical Activity in Rural Pennsylvanians: The PA Moves Trial$881,845
R01 · FY2024 · CA
Increasing Physical Activity in Rural Pennsylvanians: The PA Moves Trial$975,560
R01 · FY2023 · CA
Increasing Physical Activity in Rural Pennsylvanians: The PA Moves Trial$1,021,979
R01 · FY2022 · CA
Identification of Microbiome Based Markers to Improve Colorectal Cancer Detection$319,318
R01 · FY2021 · CA
Identification of Microbiome Based Markers to Improve Colorectal Cancer Detection$340,154
R01 · FY2020 · CA
Identification of Microbiome Based Markers to Improve Colorectal Cancer Detection$131,521
R01 · FY2019 · CA
Identification of Microbiome Based Markers to Improve Colorectal Cancer Detection$627,529
R01 · FY2018 · CA
P2 - Markers of Pancreatic Cancer Using a Glycoproteomic Approach$133,699
P50 · FY2014 · CA · contact PI
HPV IMMUNIZATION RESPONSE AND STRESS$129,705
P50 · FY2014 · CA · contact PI
P2 - Markers of Pancreatic Cancer Using a Glycoproteomic Approach$236,084
P50 · FY2013 · CA · contact PI
HPV IMMUNIZATION RESPONSE AND STRESS$153,430
P50 · FY2013 · CA · contact PI
P2 - Markers of Pancreatic Cancer Using a Glycoproteomic Approach$218,771
P50 · FY2012 · CA · contact PI
HPV IMMUNIZATION RESPONSE AND STRESS$154,314
P50 · FY2012 · CA · contact PI
P2 - Markers of Pancreatic Cancer Using a Glycoproteomic Approach$219,392
P50 · FY2011 · CA · contact PI
HPV IMMUNIZATION RESPONSE AND STRESS$158,693
P50 · FY2011 · CA · contact PI
Cancer Chemoprevention and Mentoring Clinical Researchers$182,264
K24 · FY2010 · CA · contact PI
P2 - Markers of Pancreatic Cancer Using a Glycoproteomic Approach$159,389
P50 · FY2010 · CA · contact PI
HPV IMMUNIZATION RESPONSE AND STRESS$147,317
P50 · FY2010 · CA · contact PI
Cancer Chemoprevention and Mentoring Clinical Researchers$178,529
K24 · FY2009 · CA · contact PI
Cancer Chemoprevention and Mentoring Clinical Researchers$174,902
K24 · FY2008 · CA · contact PI
Cancer Chemoprevention and Mentoring Clinical Researchers$171,381
K24 · FY2007 · CA · contact PI
Cancer Chemoprevention and Mentoring Clinical Researchers$167,962
K24 · FY2006 · CA · contact PI
HPV INFECTION AND HIGH FRUIT AND VEGETABLE DIET: PILOT PROJECT$8,175
M01 · FY2006 · RR · contact PI
HPV INFECTION AND HIGH FRUIT AND VEGETABLE DIET: PILOT PROJECT$31,908
M01 · FY2005 · RR
HUMAN PAPILLOMAVIRUS IN MEN "HIM": PILOT STUDY$14,409
M01 · FY2005 · RR
HPV Infection and High Fruit and Vegetable Diet: Pilot Project$11,182
M01 · FY2004 · RR
CANCER CHEMOPREVENTION &MENTORING CLINICAL RESEARCHERS$118,062
K24 · FY2003 · CA
CANCER CHEMOPREVENTION &MENTORING CLINICAL RESEARCHERS$114,822
K24 · FY2002 · CA
ALL-TRANS-RETINOIC ACID (ATRA) IN WOMEN WITH CERVICAL INTRAEPITHELIAL NEOPLASIA$0
M01 · FY2002 · RR
CANCER CHEMOPREVENTION &MENTORING CLINICAL RESEARCHERS$118,062
K24 · FY2001 · CA
CANCER CHEMOPREVENTION &MENTORING CLINICAL RESEARCHERS$118,062
K24 · FY2000 · CA
ALL-TRANS-RETINOIC ACID (ATRA) IN WOMEN WITH CERVICAL INTRAEPITHELIAL NEOPLASIA$0
M01 · FY2000 · RR